Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition
Haruka Okamoto(Regeneron (United States)), Jesper Gromada(Rapt Therapeutics (United States))
Cited by 20
Related Papers
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways
|Diabetes|2006|491
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2017|329
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
|Journal of Lipid Research|2020|202
Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action
|Journal of Clinical Investigation|2005|107